Citryll

Healthcare & Life Sciences

Recent Finacing

Series B

Recent Raise

$89.8M

Citryll is a biotech company developing therapies for immune-mediated inflammatory diseases, focusing on a monoclonal antibody targeting Neutrophil Extracellular Traps (NETs).